logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Gastric Adenocarcinoma

    FiltersReset Filters
    7 results

    • fluorouracil

      (Fluorouracil)
      Alembic Pharmaceuticals Inc.
      Usage: Fluorouracil is indicated for the treatment of patients with adenocarcinoma of the colon and rectum, breast, gastric, and pancreatic adenocarcinoma.

    • fluorouracil

      (Fluorouracil)
      BluePoint Laboratories
      Usage: Fluorouracil is indicated for treating patients with adenocarcinoma of the colon and rectum, breast, stomach, and pancreas.

    • fluorouracil

      (Fluorouracil)
      BluePoint Laboratories
      Usage: Fluorouracil is indicated for the treatment of patients with adenocarcinomas, specifically of the colon and rectum, breast, gastric, and pancreas.

    • fluorouracil

      (Fluorouracil)
      Alembic Pharmaceuticals Inc.
      Usage: This drug is indicated for the treatment of various adenocarcinomas, specifically adenocarcinoma of the colon and rectum, breast, gastric, and pancreatic regions.

    • fluorouracil

      (fluorouracil)
      Sagent Pharmaceuticals
      Usage: Fluorouracil Injection is indicated for treating adenocarcinoma of the colon and rectum, breast, gastric, and pancreatic cancer.

    • fluorouracil

      (FLUOROURACIL)
      Eugia US LLC
      Usage: Fluorouracil injection is indicated for treating patients with adenocarcinomas of the colon, rectum, breast, gastric, and pancreatic origins.

    • tevimbra

      (tislelizumab-jsgr)
      BEIGENE USA, INC.
      Usage: TEVIMBRA is indicated for the first-line treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) expressing PD-L1 (≥1), in combination with chemotherapy, or as a single agent after prior chemotherapy. It is also indicated for first-line treatment of HER2-negative gastric/gastroesophageal junction adenocarcinoma with PD-L1 expression.